OTCMKTS:ITGDF Integral Diagnostics (ITGDF) Stock Price, News & Analysis $2.10 0.00 (0.00%) As of 08/15/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartShort InterestBuy This Stock About Integral Diagnostics Stock (OTCMKTS:ITGDF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Integral Diagnostics alerts:Sign Up Key Stats Today's Range$2.10▼$2.1050-Day Range$2.10▼$2.1052-Week Range$0.96▼$2.10VolumeN/AAverage Volume100 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Integral Diagnostics Ltd (OTCMKTS:ITGDF) is a leading provider of diagnostic imaging services in Australia. The company operates a network of outpatient imaging centres, offering a full spectrum of modalities including magnetic resonance imaging (MRI), computed tomography (CT), X-ray, ultrasound, nuclear medicine and interventional radiology. Through its clinics, Integral Diagnostics delivers clinically focused imaging solutions to support the diagnosis and management of a wide range of medical conditions. Integral Diagnostics combines advanced imaging technology with a team of specialist radiologists, sonographers and technologists to ensure high-quality patient care. The company also offers teleradiology services, enabling rapid, remote interpretation of imaging studies to meet the needs of hospitals, general practitioners and specialist referrers. Its emphasis on clinical governance, quality assurance and innovation helps maintain consistency of service across its network. Headquartered in Melbourne, Victoria, Integral Diagnostics serves both metropolitan and regional communities across Australia. The company partners with public and private healthcare providers to expand access to diagnostic imaging, striving to improve patient outcomes by providing timely and accurate diagnostic information. Integral Diagnostics continues to develop its service footprint with a focus on enhancing healthcare delivery through imaging excellence.AI Generated. May Contain Errors. Read More Receive ITGDF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Integral Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address ITGDF Stock News HeadlinesAidoc and Integral Diagnostics (IDX) Expand AI Partnership in Australia and New ZealandOctober 15, 2024 | tmcnet.comSee More Headlines ITGDF Stock Analysis - Frequently Asked Questions How have ITGDF shares performed this year? Integral Diagnostics' stock was trading at $2.10 at the beginning of the year. Since then, ITGDF stock has increased by 0.0% and is now trading at $2.10. How do I buy shares of Integral Diagnostics? Shares of ITGDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolOTCMKTS:ITGDF CIKN/A Webwww.integraldiagnostics.com.au Phone61-3-5339-0704FaxN/AEmployees2,010Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free Report This page (OTCMKTS:ITGDF) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersOne tiny company just cracked Google’s $19B problemGoogle, Microsoft, IBM… every major AI player will be forced to secure massive amounts of this material just t...True Market Insiders | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredCould This Be the End of Retirement Worries?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integral Diagnostics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Integral Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.